• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌组织中 ALS 患者与年龄匹配健康对照者微小 RNA 和其他小 RNA 的差异表达。

Differential expression of microRNAs and other small RNAs in muscle tissue of patients with ALS and healthy age-matched controls.

机构信息

Department of Biotechnology, Jozef Stefan Institute, Jamova 39, Ljubljana, Slovenia.

Institute of Clinical Neurophysiology, Division of Neurology, University Medical Centre Ljubljana, Zaloška cesta 7, Ljubljana, Slovenia.

出版信息

Sci Rep. 2018 Apr 4;8(1):5609. doi: 10.1038/s41598-018-23139-2.

DOI:10.1038/s41598-018-23139-2
PMID:29618798
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5884852/
Abstract

Amyotrophic lateral sclerosis is a late-onset disorder primarily affecting motor neurons and leading to progressive and lethal skeletal muscle atrophy. Small RNAs, including microRNAs (miRNAs), can serve as important regulators of gene expression and can act both globally and in a tissue-/cell-type-specific manner. In muscle, miRNAs called myomiRs govern important processes and are deregulated in various disorders. Several myomiRs have shown promise for therapeutic use in cellular and animal models of ALS; however, the exact miRNA species differentially expressed in muscle tissue of ALS patients remain unknown. Following small RNA-Seq, we compared the expression of small RNAs in muscle tissue of ALS patients and healthy age-matched controls. The identified snoRNAs, mtRNAs and other small RNAs provide possible molecular links between insulin signaling and ALS. Furthermore, the identified miRNAs are predicted to target proteins that are involved in both normal processes and various muscle disorders and indicate muscle tissue is undergoing active reinnervation/compensatory attempts thus providing targets for further research and therapy development in ALS.

摘要

肌萎缩侧索硬化症是一种迟发性疾病,主要影响运动神经元,导致进行性和致命的骨骼肌萎缩。小 RNA,包括 microRNAs(miRNAs),可以作为基因表达的重要调节剂,既可以全局作用,也可以组织/细胞类型特异性作用。在肌肉中,称为肌源性 miRNAs 的 miRNAs 控制着重要的过程,并在各种疾病中失调。一些肌源性 miRNAs 在 ALS 的细胞和动物模型中显示出治疗应用的潜力;然而,ALS 患者肌肉组织中差异表达的确切 miRNA 种类仍不清楚。在进行了小 RNA-Seq 之后,我们比较了 ALS 患者和年龄匹配的健康对照组肌肉组织中小 RNA 的表达。鉴定出的 snoRNAs、mtRNAs 和其他小 RNA 为胰岛素信号与 ALS 之间提供了可能的分子联系。此外,鉴定出的 miRNAs 预测靶向参与正常过程和各种肌肉疾病的蛋白质,表明肌肉组织正在进行主动再神经支配/代偿尝试,从而为 ALS 的进一步研究和治疗开发提供了目标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f37/5884852/e96ac9269c3e/41598_2018_23139_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f37/5884852/086d2a96142d/41598_2018_23139_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f37/5884852/09d6e8d2e7db/41598_2018_23139_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f37/5884852/79ef6ba58d65/41598_2018_23139_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f37/5884852/e96ac9269c3e/41598_2018_23139_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f37/5884852/086d2a96142d/41598_2018_23139_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f37/5884852/09d6e8d2e7db/41598_2018_23139_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f37/5884852/79ef6ba58d65/41598_2018_23139_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f37/5884852/e96ac9269c3e/41598_2018_23139_Fig4_HTML.jpg

相似文献

1
Differential expression of microRNAs and other small RNAs in muscle tissue of patients with ALS and healthy age-matched controls.肌组织中 ALS 患者与年龄匹配健康对照者微小 RNA 和其他小 RNA 的差异表达。
Sci Rep. 2018 Apr 4;8(1):5609. doi: 10.1038/s41598-018-23139-2.
2
Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression.肌肉组蛋白去乙酰化酶 4 在肌萎缩侧索硬化症中的上调:在重新支配能力和疾病进展中的潜在作用。
Brain. 2013 Aug;136(Pt 8):2359-68. doi: 10.1093/brain/awt164. Epub 2013 Jul 3.
3
Identification of a circulating miRNA signature in extracellular vesicles collected from amyotrophic lateral sclerosis patients.从肌萎缩侧索硬化症患者的细胞外囊泡中鉴定出循环 miRNA 特征。
Brain Res. 2019 Apr 1;1708:100-108. doi: 10.1016/j.brainres.2018.12.016. Epub 2018 Dec 12.
4
Skeletal Muscle MicroRNAs as Key Players in the Pathogenesis of Amyotrophic Lateral Sclerosis.骨骼肌 microRNAs 在肌萎缩侧索硬化症发病机制中的关键作用。
Int J Mol Sci. 2018 May 22;19(5):1534. doi: 10.3390/ijms19051534.
5
Up-regulation of neural and cell cycle-related microRNAs in brain of amyotrophic lateral sclerosis mice at late disease stage.肌萎缩侧索硬化症小鼠疾病晚期大脑中神经和细胞周期相关微小RNA的上调。
Mol Brain. 2015 Jan 28;8:5. doi: 10.1186/s13041-015-0095-0.
6
Altered microRNA expression profile in Amyotrophic Lateral Sclerosis: a role in the regulation of NFL mRNA levels.肌萎缩侧索硬化症中微小 RNA 表达谱的改变:在 NFL mRNA 水平调节中的作用。
Mol Brain. 2013 May 24;6:26. doi: 10.1186/1756-6606-6-26.
7
Micro-RNAs in ALS muscle: Differences in gender, age at onset and disease duration.肌萎缩侧索硬化症肌肉中的 micro-RNAs:性别、发病年龄和疾病持续时间的差异。
J Neurol Sci. 2017 Sep 15;380:58-63. doi: 10.1016/j.jns.2017.07.008. Epub 2017 Jul 6.
8
Identification of plasma microRNAs as a biomarker of sporadic Amyotrophic Lateral Sclerosis.鉴定血浆微小RNA作为散发性肌萎缩侧索硬化症的生物标志物
Mol Brain. 2015 Oct 24;8(1):67. doi: 10.1186/s13041-015-0161-7.
9
Potential therapeutic targets for ALS: MIR206, MIR208b and MIR499 are modulated during disease progression in the skeletal muscle of patients.肌萎缩侧索硬化症的潜在治疗靶点:在患者骨骼肌疾病进展过程中,MIR206、MIR208b 和 MIR499 受到调节。
Sci Rep. 2017 Aug 25;7(1):9538. doi: 10.1038/s41598-017-10161-z.
10
Analysis of novel NEFL mRNA targeting microRNAs in amyotrophic lateral sclerosis.分析肌萎缩侧索硬化症中新型 NEFL mRNA 靶向 microRNAs。
PLoS One. 2014 Jan 15;9(1):e85653. doi: 10.1371/journal.pone.0085653. eCollection 2014.

引用本文的文献

1
MicroRNA biomarkers as next-generation diagnostic tools for neurodegenerative diseases: a comprehensive review.微小RNA生物标志物作为神经退行性疾病的下一代诊断工具:综述
Front Mol Neurosci. 2024 May 31;17:1386735. doi: 10.3389/fnmol.2024.1386735. eCollection 2024.
2
MiR206 and 423-3p Are Differently Modulated in Fast and Slow-Progressing Amyotrophic Lateral Sclerosis Patients.miR206 和 423-3p 在快速进展型和缓慢进展型肌萎缩侧索硬化症患者中存在差异表达。
Neuromolecular Med. 2024 Mar 15;26(1):5. doi: 10.1007/s12017-024-08773-6.
3
Small non-coding RNA profiling in patients with gastrointestinal cancer.

本文引用的文献

1
Potential therapeutic targets for ALS: MIR206, MIR208b and MIR499 are modulated during disease progression in the skeletal muscle of patients.肌萎缩侧索硬化症的潜在治疗靶点:在患者骨骼肌疾病进展过程中,MIR206、MIR208b 和 MIR499 受到调节。
Sci Rep. 2017 Aug 25;7(1):9538. doi: 10.1038/s41598-017-10161-z.
2
Serum miRNAs miR-206, 143-3p and 374b-5p as potential biomarkers for amyotrophic lateral sclerosis (ALS).血清微小RNA miR-206、143-3p和374b-5p作为肌萎缩侧索硬化症(ALS)的潜在生物标志物。
Neurobiol Aging. 2017 Jul;55:123-131. doi: 10.1016/j.neurobiolaging.2017.03.027. Epub 2017 Apr 1.
3
Genetics of amyotrophic lateral sclerosis.
胃肠道癌患者的小型非编码 RNA 谱分析。
J Cachexia Sarcopenia Muscle. 2023 Dec;14(6):2692-2702. doi: 10.1002/jcsm.13343. Epub 2023 Sep 24.
4
FUS regulates a subset of snoRNA expression and modulates the level of rRNA modifications.FUS 调节一组 snoRNA 的表达并调节 rRNA 修饰的水平。
Sci Rep. 2023 Feb 20;13(1):2974. doi: 10.1038/s41598-023-30068-2.
5
Recent Advances in the Roles of MicroRNA and MicroRNA-Based Diagnosis in Neurodegenerative Diseases.近年来 microRNA 及其在神经退行性疾病中的诊断作用的研究进展。
Biosensors (Basel). 2022 Nov 24;12(12):1074. doi: 10.3390/bios12121074.
6
miRNA analysis reveals novel dysregulated pathways in amyotrophic lateral sclerosis.miRNA 分析揭示肌萎缩侧索硬化症中 novel dysregulated 通路。
Hum Mol Genet. 2023 Mar 6;32(6):934-947. doi: 10.1093/hmg/ddac250.
7
Structural environmental enrichment and the way it is offered influence cognitive judgement bias and anxiety-like behaviours in zebrafish.结构性环境富集及其提供方式会影响斑马鱼的认知判断偏差和类似焦虑的行为。
Anim Cogn. 2023 Mar;26(2):563-577. doi: 10.1007/s10071-022-01700-x. Epub 2022 Oct 9.
8
A Review of Molecular Interplay between Neurotrophins and miRNAs in Neuropsychological Disorders.神经递质与 microRNAs 在神经心理障碍中的分子相互作用综述。
Mol Neurobiol. 2022 Oct;59(10):6260-6280. doi: 10.1007/s12035-022-02966-5. Epub 2022 Aug 2.
9
Shared and Divergent Epigenetic Mechanisms in Cachexia and Sarcopenia.恶病质和肌肉减少症中的共享和差异表观遗传机制。
Cells. 2022 Jul 25;11(15):2293. doi: 10.3390/cells11152293.
10
MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases.微小 RNA 改变、作为生物标志物的应用及在神经退行性疾病中的治疗方法。
Int J Mol Sci. 2022 Apr 25;23(9):4718. doi: 10.3390/ijms23094718.
肌萎缩侧索硬化症的遗传学
Rev Neurol (Paris). 2017 May;173(5):254-262. doi: 10.1016/j.neurol.2017.03.030. Epub 2017 Apr 25.
4
MicroRNA Profiling Reveals Marker of Motor Neuron Disease in ALS Models.微小RNA分析揭示肌萎缩侧索硬化症模型中运动神经元疾病的标志物。
J Neurosci. 2017 May 31;37(22):5574-5586. doi: 10.1523/JNEUROSCI.3582-16.2017. Epub 2017 Apr 17.
5
Humanin Specifically Interacts with Amyloid-β Oligomers and Counteracts Their in vivo Toxicity.人胰岛素特异性地与β-淀粉样蛋白寡聚体相互作用并抵消其体内毒性。
J Alzheimers Dis. 2017;57(3):857-871. doi: 10.3233/JAD-160951.
6
ZNF598 and RACK1 Regulate Mammalian Ribosome-Associated Quality Control Function by Mediating Regulatory 40S Ribosomal Ubiquitylation.锌指蛋白598(ZNF598)和活化C激酶1受体(RACK1)通过介导40S核糖体调控泛素化来调节哺乳动物核糖体相关质量控制功能。
Mol Cell. 2017 Feb 16;65(4):751-760.e4. doi: 10.1016/j.molcel.2016.12.026. Epub 2017 Jan 26.
7
Investigating the role of ALS genes CHCHD10 and TUBA4A in Belgian FTD-ALS spectrum patients.研究肌萎缩侧索硬化症相关基因CHCHD10和TUBA4A在比利时额颞叶痴呆-肌萎缩侧索硬化症谱系患者中的作用。
Neurobiol Aging. 2017 Mar;51:177.e9-177.e16. doi: 10.1016/j.neurobiolaging.2016.12.008. Epub 2016 Dec 21.
8
Humanin skeletal muscle protein levels increase after resistance training in men with impaired glucose metabolism.在糖代谢受损的男性中,进行抗阻训练后,人胰岛素(Humanin)在骨骼肌中的蛋白水平会升高。
Physiol Rep. 2016 Dec;4(23). doi: 10.14814/phy2.13063.
9
Decoding ALS: from genes to mechanism.解码肌萎缩侧索硬化症:从基因到机制
Nature. 2016 Nov 10;539(7628):197-206. doi: 10.1038/nature20413.
10
In Vivo Formation of Vacuolated Multi-phase Compartments Lacking Membranes.缺乏膜的空泡状多相区室的体内形成。
Cell Rep. 2016 Aug 2;16(5):1228-1236. doi: 10.1016/j.celrep.2016.06.088. Epub 2016 Jul 21.